I received an ad for a subscription to Oxford (highly discounted) for $49, where Alexander Green speaks about a $10 AI stock that’s in the medical field namely drug development run by a ex-employee of Pfizer and someone with ties to Oxford. Any clues would be appreciated. Off the top of my head I’m thinking […]